Find a Trial
Trial Summary
| Protocol No. | PHO-COG-AALL1821 | ||
|---|---|---|---|
| Status | OPEN TO ACCRUAL | ||
| Principal Investigator | Batra, Sandeep | ||
| Scope | National | ||
| Phase | Phase II | ||
| Age Group | Adults and Children | ||
| Title | AALL1821, A Phase 2 Study of Blinatumomab (NSC # 765986, IND # 125462) in Combination with Nivolumab (NSC # 748726, IND # 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged equal to or more than 1 to less than 31 Years Old with First Relapse. | ||
| Applicable Disease Sites | Lymphoid Leukemia | ||
| Participating Institutions | Indiana University (IU) | ||
| Treatment Type | Treatment | ||
| Contact | Sara Quetant, | Phone: Pager: Email: squetant@iu.edu | |